JPMorgan Lowers XPeng Price Target to $24
- Rating
- Buy
- Target
- $24
- from $27 (−11%)
- Upside
- +161%
- XPEV at $9.21 today
What the analyst said
JPMorgan analyst Nick Lai lowered the price target on XPeng (NYSE: XPEV) to $24 (from $27) while maintaining an Overweight rating.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
XPEV trades at $9.21. The 7 analysts who set a target in the last 3 months range from $11.50 to $22, with a median of $16. This $24 target is 50% above the median, the highest on the Street.
Since the note XPEV has moved −17% (from $11.15). 12-month window: day 61 of 365, closes on August 25, 2027.
Track record
This callOpen: XPEV has not reached $24 yet. This 12-month target is scored on August 25, 2027.
Firm track recordJP Morgan: 56% of its 16 targets at least a year old were reached within 12 months (#26 of 28 firms). Accuracy ranking →
JP Morgan on XPeng
JP Morgan price targets on XPeng
4 calls from February 9, 2026 to September 29, 2026. The target went from $34 to $11.50 (−66%). The rating moved from Buy to Hold.
- September 29, 2026Downgraded to Hold, target cut from $24 (−52%)Hold$11.50
- August 25, 2026 This noteTarget cut from $30 (−20%)Buy$24
- May 29, 2026Target cut from $34 (−12%)Buy$30
- February 9, 2026Earliest call shownBuy$34
